The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

avalynpharma.com

Total Raised

$99.68M

Investors Count

10

Deal Terms

1

Avalyn Pharma Funding, Avalyn Pharma Valuation & Avalyn Pharma Revenue

3 Fundings

Avalyn Pharma's latest funding round was a Series B for $35.5M on April 27, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/27/2020

Series B

$35.5M

0

FY undefined

10

3/24/2017

Series A

$99M

0

FY undefined

10

11/8/2012

Seed VC

$99M

0

FY undefined

10

Date

4/27/2020

3/24/2017

11/8/2012

Round

Series B

Series A

Seed VC

Amount

$35.5M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

10

10

10

Avalyn Pharma Deal Terms

1 Deal Term

Avalyn Pharma's deal structure is available for 1 funding round, including their Series A from March 24, 2017.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Avalyn Pharma Investors

10 Investors

Avalyn Pharma has 10 investors. RiverVest Venture Partners invested in Avalyn Pharma's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/24/2017

4/27/2020

2
Series A, Series B (2020)

Venture Capital

Missouri

3/24/2017

4/27/2020

2
Series A, Series B (2020)

Venture Capital

New York

3/24/2017

4/27/2020

2
Series A, Series B (2020)

Venture Capital

California

00/00/0000

00/00/0000

F-Prime Capital

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Norwest Venture Partners

Subscribe to see more

Venture Capital

California

First funding

3/24/2017

3/24/2017

3/24/2017

00/00/0000

00/00/0000

Last Funding

4/27/2020

4/27/2020

4/27/2020

00/00/0000

00/00/0000

Investor

F-Prime Capital

Norwest Venture Partners

Rounds

2
Series A, Series B (2020)
2
Series A, Series B (2020)
2
Series A, Series B (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

Missouri

New York

California

Massachusetts

California

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.